These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7389252)

  • 1. Propranolol dynamics in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1980 Jul; 28(1):40-4. PubMed ID: 7389252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease.
    Feely J; Isles TE; Ratcliffe WA; Crooks J
    Clin Endocrinol (Oxf); 1979 May; 10(5):531-8. PubMed ID: 476982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol dosage in thyrotoxicosis.
    Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J
    J Clin Endocrinol Metab; 1980 Sep; 51(3):658-61. PubMed ID: 7410541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.
    Nilsson OR; Melander A; Tegler L
    Eur J Clin Pharmacol; 1980 Oct; 18(4):315-20. PubMed ID: 7439251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis.
    Saunders J; Hall SE; Crowther A; Sönksen PH
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):67-72. PubMed ID: 679503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol as primary therapy for thyrotoxicosis.
    Mazzaferri EL; Reynolds JC; Young RL; Thomas CN; Parisi AF
    Arch Intern Med; 1976 Jan; 136(1):50-6. PubMed ID: 1108824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol and hyperthyroidism: sequential changes in serum iodothyronine (T4, T3, rT3) concentrations during therapy until clinical remission.
    Pinho MO; Medeiros YS; Rosenthal D; Francalanci CC
    Braz J Med Biol Res; 1983 Jul; 16(2):111-7. PubMed ID: 6652288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular responses in hyperthyroidism before and during beta-adrenoceptor blockade: evidence against adrenergic hypersensitivity.
    Forfar JC; Stewart J; Sawers A; Toft AD
    Clin Endocrinol (Oxf); 1982 May; 16(5):441-52. PubMed ID: 7083598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction by propranolol of urinary hydroxyproline excretion in human hyperthyroidism: a beta-receptor blockade effect or a membrane stabilizing mechanism?
    Beylot M; Borson F; David L; Sautot G; Riou JP; Mornex R
    Metabolism; 1984 Feb; 33(2):124-8. PubMed ID: 6694555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of increased levels of blood glycerol and ketone bodies by propranolol in human hyperthyroidism: role of the fall of the triiodothyronine level.
    Beylot M; Riou JP; Borson F; Cohen R; Sautot G; Mornex R
    Metabolism; 1984 Dec; 33(12):1080-3. PubMed ID: 6503708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of propranolol on thyroid hormones in T3 toxicosis.
    Jones MK; Owens DR; Jones GR; Birtwell J
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):621-3. PubMed ID: 7296908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report on the use of propranolol in thyrotoxicosis: I. Effect on serum thyroxine, triiodothyronine and reverse triiodothyronine concentrations.
    Tevaarwerk GJ; Malik MH; Boyd D
    Can Med Assoc J; 1978 Aug; 119(4):350-1, 360. PubMed ID: 688126
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of propranolol on serum levels of T4, T3 and reverse-T3 in hyperthyroidism.
    Kallner G; Ljunggren JG; Tryselius M
    Acta Med Scand; 1978; 204(1-2):35-7. PubMed ID: 685727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Propranolol treatment in thyrotoxicosis].
    Cullhed I; Parrow A
    Lakartidningen; 1969 Sep; 66(39):3961-5. PubMed ID: 5384300
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acetylation phenotype and serum levels of T3 and T4 in patients with hypertension treated with propranolol].
    Gasińska T; Nowak S; Wawrzyniak L; Widala E
    Endokrynol Pol; 1989; 40(6):301-6. PubMed ID: 2485732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent.
    Ljunggren JG; Persson B
    Acta Chir Scand; 1975; 141(8):715-8. PubMed ID: 3081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased clearance of propranolol in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
    Wilkinson R; Burr WA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1160-7. PubMed ID: 6148879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum T4, T3 and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and in normal man.
    Faber J; Friis T; Kirkegaard C; Lumholtz IB; Hansen JM; Siersbaek-Nielsen K; Skovsted L; Theilade P
    Horm Metab Res; 1979 Jan; 11(1):34-6. PubMed ID: 428906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thyroid hormone on left ventricular function in patients treated for thyrotoxicosis.
    Cohen MV; Schulman IC; Spenillo A; Surks MI
    Am J Cardiol; 1981 Jul; 48(1):33-8. PubMed ID: 7246445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.